These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 6253914)

  • 1. Molecular structure of the immunity gene and immunity protein of the bacteriocinogenic plasmid Clo DF13.
    van den Elzen PJ; Gaastra W; Spelt CE; de Graaf FK; Veltkamp E; Nijkamp HJ
    Nucleic Acids Res; 1980 Oct; 8(19):4349-63. PubMed ID: 6253914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular structure and function of the bacteriocin gene and bacteriocin protein of plasmid Clo DF13.
    van den Elzen PJ; Walters HH; Veltkamp E; Nijkamp HJ
    Nucleic Acids Res; 1983 Apr; 11(8):2465-77. PubMed ID: 6344017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacteriocinogenic Clo DF13 minicells of Escherichia coli synthesize a protein that accounts for immunity to bacteriocin Clo DF13: purification and characterization of the immunity protein.
    Kool AJ; Pols C; Nijkamp HJ
    Antimicrob Agents Chemother; 1975 Jul; 8(1):67-75. PubMed ID: 1099983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacteriocinogenic Clo DF13 minicells of Escherichia coli synthesize a protein that accounts for immunity to bacteriocin Clo DF16: action of the immunity protein in vivo and in vitro.
    Kool AJ; Borstlap AJ; Nijkamp HJ
    Antimicrob Agents Chemother; 1975 Jul; 8(1):76-85. PubMed ID: 1099984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular structure and immunity specificity of colicin E6, an evolutionary intermediate between E-group colicins and cloacin DF13.
    Akutsu A; Masaki H; Ohta T
    J Bacteriol; 1989 Dec; 171(12):6430-6. PubMed ID: 2687234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mode of action of the cloacin DF13-immunity protein.
    Oudega B; Klaasen-Boor P; De Graaf FK
    Biochim Biophys Acta; 1975 May; 392(1):184-95. PubMed ID: 1092372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nucleotide sequence of the bacteriocin promoters of plasmids Clo DF13 and Co1 E1: role of lexA repressor and cAMP in the regulation of promoter activity.
    van den Elzen PJ; Maat J; Walters HH; Veltkamp E; Nijkamp HJ
    Nucleic Acids Res; 1982 Mar; 10(6):1913-28. PubMed ID: 6281726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clo DF13 plasmid deoxyribonucleic acid-directed in vitro synthesis of biologically active cloacin DF13 and clo DF13 immunity protein.
    Konings RN; Andreoli PM; Veltkamp E; Nijkamp HJ
    J Bacteriol; 1976 May; 126(2):861-8. PubMed ID: 770456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic map of the bacteriocinogenic plasmid CLO DF13 derived by insertion of the transposon Tn901.
    Andreoli PM; Overbeeke N; Veltkamp E; van Embden JD; Nijkamp HJ
    Mol Gen Genet; 1978 Mar; 160(1):1-11. PubMed ID: 347243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Replication and structure of the bacteriocinogenic plasmids Clo DF13 and CoI E1.
    Veltkamp E; Stuitje AR
    Plasmid; 1981 Jan; 5(1):76-99. PubMed ID: 6164067
    [No Abstract]   [Full Text] [Related]  

  • 11. Mutants of the Clo DF13 plasmid in Escherichia coli with a decreased bacteriocinogenic activity.
    Andreoli PM; Nijkamp HJ
    Mol Gen Genet; 1976 Mar; 144(2):159-70. PubMed ID: 775289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Replication of the bacteriocinogenic plasmid Clo DF13: action of the plasmid protein cloacin DF13 on Clo DF13 DNA.
    Veltkamp E; Pols K; van Ee JH; Nijkamp HJ
    J Mol Biol; 1976 Sep; 106(1):75-95. PubMed ID: 787544
    [No Abstract]   [Full Text] [Related]  

  • 13. Protein H encoded by plasmid CloDF13 is involved in excretion of cloacin DF13.
    Oudega B; Stegehuis F; van Tiel-Menkveld GJ; de Graaf FK
    J Bacteriol; 1982 Jun; 150(3):1115-21. PubMed ID: 6281236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uncoupling of synthesis and release of cloacin DF13 and its immunity protein by Escherichia coli.
    Luirink J; de Graaf FK; Oudega B
    Mol Gen Genet; 1987 Jan; 206(1):126-32. PubMed ID: 3553860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of messenger ribonucleic acids and proteins synthesized by the bacteriocinogenic factor Clo DF13 in purified minicells of Escherichia coli.
    Kool AJ; van Zeben MS; Nijkamp HJ
    J Bacteriol; 1974 Apr; 118(1):213-24. PubMed ID: 4595198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of bacteriocin Clo DF13 to Clo DF13 plasmid deoxyribonucleic acid in vivo and in vitro.
    Veltkamp E; Blankevoort R; Nijkamp HJ
    Antimicrob Agents Chemother; 1975 Sep; 8(3):356-65. PubMed ID: 1101824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mode of action of colicin E2, colicin E3 and cloacin DF13.
    De Graaf FK
    Zentralbl Bakteriol Orig A; 1979 Jun; 244(1):121-34. PubMed ID: 506538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uptake of cloacin DF13 by susceptible cells: removal of immunity protein and fragmentation of cloacin molecules.
    Krone WJ; de Vries P; Koningstein G; de Jonge AJ; de Graaf FK; Oudega B
    J Bacteriol; 1986 Apr; 166(1):260-8. PubMed ID: 2420782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro construction of deletion mutants of the bacteriocinogenic plasmid Clo DF13.
    Stuitje AR; Veltkamp E; van den Elzen PJ; Nijkamp HJ
    Nucleic Acids Res; 1978 Jun; 5(6):1801-20. PubMed ID: 353730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Origin and direction of replication of the bacteriocinogenic plasmid Clo DF13.
    Stuitje AR; Veltkamp E; Weijers PJ; Nijkamp HJ
    Nucleic Acids Res; 1979 Jan; 6(1):71-80. PubMed ID: 370788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.